Literature DB >> 21390579

Anticolchicine cytotoxicity enhanced by Dan Gua-Fang, a Chinese herb prescription in ECV304 in mediums.

Xian-Pei Heng1, Ke-Ji Chen, Zhen-Feng Hong, Wei-Dong He, Ke-Dan Chu, Wen-Lie Chen, Hai-Xia Zheng, Liu-Qing Yang, Ling Chen, Fang Guo.   

Abstract

OBJECTIVE: To study the effect of anticolchicine cytotoxicity of Dan Gua-Fang, a Chinesea Chinese), a Chinese herbal compound prescription on endothelial cells of vein (ECV304) cultivated in mediums of different glucose concentrations as well as the proliferation of those cells in the same conditions, in order to reveal the value of Dan Gua-Fang in preventing and treating endothelial damage caused by hyperglycemia in diabetes mellitus.
METHODS: The research was designed as three stages. The growing state and morphological changes were observed when ECV304 were cultivated in the culture mediums, which have different glucose concentrations with or without Dan Gua-Fang and at the same time with or without colchicine.
RESULTS: (1) Dan Gua-Fang at all concentrations reduced the floating cell population of ECV304 cultivated in hyperglycemia mediums. (2) Dan Gua-Fang at all concentrations and hyperglycemia both had a function of promoting "pseudopod-like" structure formation in cultivated ECV304, but the function was not superimposed in mediums containing both hyperglycemia and Dan Gua-Fang. (3) Colchicine reduced and even vanished the "pseudopod-like" structure of the endotheliocyte apparently cultivated in mediums of hyperglycemia or with Dan Gua-Fang. The "pseudopod-like" structure of the endotheliocyte emerged quickly in Dan Gua-Fang groups after colchicine was removed, but it was not the case in hyperglycemia only without Dan Gua-Fang groups. (4) Dan Gua-Fang reduced the mortality of cells cultivated in mediums containing colchicine. The cell revived to its normal state fast after colchicine was removed.
CONCLUSION: Dan Gua-Fang has the functions of promoting the formation of cytoskeleton and fighting against colchicine cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21390579     DOI: 10.1007/s11655-011-0646-X

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  9 in total

1.  Strategies and methods for the treatment of diabetic neuropathy using integrative Chinese and Western medicine.

Authors:  Xian-pei HENG
Journal:  Chin J Integr Med       Date:  2008-12-12       Impact factor: 1.978

2.  Distinct effects of high-glucose conditions on endothelial cells of macrovascular and microvascular origins.

Authors:  A Duffy; A Liew; J O'Sullivan; G Avalos; A Samali; T O'Brien
Journal:  Endothelium       Date:  2006 Jan-Feb

3.  Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.

Authors:  P Kovács; G Csaba
Journal:  Cell Biochem Funct       Date:  2006 Sep-Oct       Impact factor: 3.685

4.  [Effects of colchicine on synthesis and excretion of cytokines and extracellular matrix by human renal fibroblasts].

Authors:  Wen-yan Huang; Hua Sun; Xiao-qin Pan; Li Fei; Mei Guo; Hua-ying Bao; Rong-hua Chen; Xin-you Jiang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2004-07

5.  Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton.

Authors:  N Golestaneh; C Klein; F Valamanesh; G Suarez; M K Agarwal; M Mirshahi
Journal:  Biochem Biophys Res Commun       Date:  2001-02-09       Impact factor: 3.575

6.  Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway.

Authors:  P Luppi; V Cifarelli; H Tse; J Piganelli; M Trucco
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

7.  Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

Authors:  Fernando E Ezquer; Marcelo E Ezquer; Daniela B Parrau; Daniel Carpio; Alejandro J Yañez; Paulette A Conget
Journal:  Biol Blood Marrow Transplant       Date:  2008-04-14       Impact factor: 5.742

8.  Hyperglycemia and adverse pregnancy outcomes.

Authors:  Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

9.  Glucose endothelial cytotoxicity and protection by Dan Gua-Fang, a Chinese herb prescription in huVEC in hyperglycemia medium.

Authors:  Heng Xian-pei; Chen Ke-ji; Hong Zheng-feng; He Wei-dong; Chu Ke-dan; Chen Wen-lie; Chen Xu-zheng; Zheng Hai-xia; Chen Ling; Yang Liu-qing; Guo Fang; Lin Mao-long
Journal:  J Diabetes Complications       Date:  2008-07-26       Impact factor: 2.852

  9 in total
  6 in total

1.  Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway.

Authors:  Wei Li; Wei Sun; Chuan-hua Yang; Hong-zhen Hu; Yue-hua Jiang
Journal:  Chin J Integr Med       Date:  2014-03-04       Impact factor: 1.978

Review 2.  Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go Down the Wrong Road?

Authors:  Xian-Pei Heng; Xiu-Jun Li; Liang Li; Liu-Qing Yang; Zi-Ta Wang; Su-Ping Huang
Journal:  Chin J Integr Med       Date:  2018-10-17       Impact factor: 1.978

3.  Toxicity features of high glucose on endothelial cell cycle and protection by Dan Gua-Fang in ECV-304 in high glucose medium.

Authors:  Xian-Pei Heng; Ke-Ji Chen; Zhen-Feng Hong; Wei-Dong He; Ke-Dan Chu; Jiu-Mao Lin; Hai-Xia Zheng; Liu-Qing Yang; Su-Ping Huang; Yuan-Long Lan; Ling Chen; Fang Guo
Journal:  Chin J Integr Med       Date:  2012-02-09       Impact factor: 1.978

4.  Dan-gua fang improves glycolipid metabolic disorders by promoting hepatic adenosine 5'-monophosphate activated protein kinase expression in diabetic Goto-Kakizaki rats.

Authors:  Yuan-long Lan; Su-ping Huang; Xian-pei Heng; Ling Chen; Peng-hui Li; Jing Wu; Liu-qing Yang; Xu-dong Pan; Tong Lin; Xin-ling Cheng; Qing Lin; Si-xin Chen
Journal:  Chin J Integr Med       Date:  2014-08-07       Impact factor: 1.978

5.  Paradox of using intensive lowering of blood glucose in diabetics and strategies to overcome it and decrease cardiovascular risks.

Authors:  Xian-pei Heng; Liu-qing Yang; Min-ling Chen; Liang Li; Su-ping Huang; Ying Lei
Journal:  Chin J Integr Med       Date:  2015-11-03       Impact factor: 1.978

6.  Effects of bleomycin A5 on caspase-3, P53, bcl-2 expression and telomerase activity in vascular endothelial cells.

Authors:  Yi-Deng Huang; Ping Li; Xiao Tong; Yue He; Yang Zhuo; Si-Wen Xia; Xing-Hua Luo
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.